Comparison 21. Maintenance therapy: methotrexate versus cyclophosphamide.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Death	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2 Relapse	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2.1 All relapses	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2.2 Major relapse	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2.3 Minor relapse	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3 Adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
3.1 Serious infection	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3.2 Leukopenia	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]